Literature DB >> 25663979

Cloning and expression of visfatin and screening of oligopeptides binding with visfatin.

Xin Yu Liu1, Lin Ge2, De Min Yu1.   

Abstract

PURPOSE: In the present study, we constructed an efficient expression system for visfatin and identified the peptide sequences which binding to visfatin. METHODS AND
RESULTS: The fusion protein was identified by SDS-PAGE and Western blot. The yield of visfatin was 300 mg/L culture medium with optimal conditions. The recombinant visfatin binds with insulin receptor with a dose-dependent effect. All of the 24 sequence identified by ELISA were able to bind to visfatin specifically. Among the 24 DNA sequences, there were 8 clones of AAKTPTE, 4 clones of ATTVPAS and 4 clones of MSLQQEH.
CONCLUSION: The sequence of AA(X)TPT(X) was the most frequently existed sequence in all of sequences analyzed, which suggests that AA(X)TPT(X) is likely to be the essential motif in peptides which visfatin could bind with.

Entities:  

Keywords:  Visfatin; adipokine; fusion expression; gene engineering; phage display

Year:  2014        PMID: 25663979      PMCID: PMC4307426     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  18 in total

Review 1.  Making the most of affinity tags.

Authors:  David S Waugh
Journal:  Trends Biotechnol       Date:  2005-06       Impact factor: 19.536

Review 2.  [Recombinant protein production in Escherichia coli].

Authors:  Przemysław Nuc; Katarzyna Nuc
Journal:  Postepy Biochem       Date:  2006

Review 3.  Phage display for engineering and analyzing protein interaction interfaces.

Authors:  Sachdev S Sidhu; Shohei Koide
Journal:  Curr Opin Struct Biol       Date:  2007-09-17       Impact factor: 6.809

Review 4.  The use of phage display peptide libraries for basic and translational research.

Authors:  Renee Brissette; Neil I Goldstein
Journal:  Methods Mol Biol       Date:  2007

Review 5.  Identification of biologically active peptides using random libraries displayed on phage.

Authors:  R Cortese; P Monaci; A Nicosia; A Luzzago; F Felici; G Galfré; A Pessi; A Tramontano; M Sollazzo
Journal:  Curr Opin Biotechnol       Date:  1995-02       Impact factor: 9.740

6.  Visfatin concentrations in children with leukemia before and after stem cell transplantation.

Authors:  Szymon Skoczen; Przemyslaw J Tomasik; Jolanta Gozdzik; Kamil Fijorek; Aleksandra Krasowska-Kwiecien; Oktawiusz Wiecha; Wojciech Czogala; Agnieszka Dluzniewska; Krystyna Sztefko; Jerzy Starzyk; Maciej Siedlar
Journal:  Exp Hematol       Date:  2014-01-07       Impact factor: 3.084

Review 7.  Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Authors:  Gaia Chiara Mannino; Giorgio Sesti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

8.  Visfatin causes endothelium-dependent relaxation in isolated blood vessels.

Authors:  Hideyuki Yamawaki; Naoko Hara; Muneyoshi Okada; Yukio Hara
Journal:  Biochem Biophys Res Commun       Date:  2009-04-23       Impact factor: 3.575

9.  Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.

Authors:  Raghu Adya; Bee K Tan; Anu Punn; Jing Chen; Harpal S Randeva
Journal:  Cardiovasc Res       Date:  2007-12-18       Impact factor: 10.787

Review 10.  Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions.

Authors:  S Pilz; H Mangge; B Obermayer-Pietsch; W März
Journal:  J Endocrinol Invest       Date:  2007-02       Impact factor: 4.256

View more
  1 in total

1.  Nicotinamide phosphoribosyltransferase purification using SUMO expression system.

Authors:  Trivikram R Molugu; Radu C Oita; Udeep Chawla; Sara M Camp; Michael F Brown; Joe G N Garcia
Journal:  Anal Biochem       Date:  2020-01-23       Impact factor: 3.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.